ASRS
ELVN icon

Arizona State Retirement System’s Enliven Therapeutics ELVN Stock Holding History

Arizona State Retirement System’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$660K Buy
13,007
+4,042
+45% +$172K ﹤0.01% 1405
2026
Q1 		$351K Buy
+8,965
New +$248K ﹤0.01% 1653

Other funds holding ELVN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Arizona State Retirement System's ELVN Position: Q2 2026 in Review

Arizona State Retirement System increased its Enliven Therapeutics (ELVN) stake by 45% in Q2 2026, buying an estimated $172K and bringing the position to 13,007 shares worth $660K. The position accounts for ﹤0.01% of the portfolio, ranked #1405.

Arizona State Retirement System first reported a position in ELVN in Q1 2026 and has held it in 2 quarters since. 213 funds tracked by Wall St. Rank hold ELVN as of Q2 2026.

  • Arizona State Retirement System held 13,007 shares of Enliven Therapeutics worth $660K as of Q2 2026.
  • Arizona State Retirement System bought 4,042 Enliven Therapeutics shares in Q2 2026, an estimated $172K.
  • Enliven Therapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1405 holding.
  • Arizona State Retirement System first reported a position in Enliven Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 213 funds tracked by Wall St. Rank held Enliven Therapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.